Omeros (OMER) Net Margin Growth (3y) (2013 - 2022)

Omeros (OMER) Net Margin Growth (3y) (2013 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 9,283.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -569.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 4,144.00
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Omeros 707.67 Mn 707.67 Mn 9.31 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2022 33,633.00
Mar 31, 2022 20,672.00
Dec 31, 2021 -34,618.00
Sep 30, 2021 375,954.00
Jun 30, 2021 665,438.00
Mar 31, 2021 199,123.00
Dec 31, 2020 -72,099.00
Sep 30, 2020 39,451.00
Jun 30, 2020 30,881.00
Mar 31, 2020 45,310.00
Dec 31, 2019 -22,392.00
Sep 30, 2019 28,819.00
Jun 30, 2019 11,697.00
Mar 31, 2019 103,398.00
Dec 31, 2018 23,608.00
Sep 30, 2018 -220,076.00
Jun 30, 2018 -338,372.00
Mar 31, 2018 3.36 Mn
Dec 31, 2017 1.19 Mn
Sep 30, 2017 2.75 Mn